Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Incorporating essential elements into your retirement financial plan at 50 is vital. Find out what you need to secure your future.
23,888 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
In 2026, Nike faces a pivotal test beyond revenue growth. This article explains why nike's most important question ce...
Rezervology and Titl unveil RezeLink, an AI-native platform designed to speed title searches for SoftPro users, boast...
Oracle’s 2026 story blends a sharp stock pullback with strong earnings momentum. Learn what’s driving the 18% drop, w...
The World Gold Council unveiled a blockchain-backed trust layer to link physical gold vaults with digital rails, sign...
Applied Digital faces a turning point as it reports another quarter with a strong revenue beat but a mounting debt lo...
Micron Technology has captured investor attention with a dramatic price rally. This guide breaks down what a stock sp...
The AI race keeps evolving, and Alphabet sits at the center. A rumored Anthropic cloud deal hints at how hyperscale i...
Barclays lowers Carvana's price target to $93 after a 5-for-1 stock split, while reaffirming an overweight stance as ...
UiPath faced a cautious session as its Korea cloud launch tests regional demand. This article breaks down what happen...
BP's board removed Albert Manifold as chair and another director amid governance concerns raised to the board. The mo...
Two years after NVIDIA's stock split, investors again wonder if the AI titan can reach $1,000. This article breaks do...